Matinas BioPharma Holdings, Inc.
(NYSE Mkt: MTNB)

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.

0.768

+0.017 (+2.26%)
Range 0.731 - 0.796   (8.89%)
Open 0.731
Previous Close 0.751
Bid Price 1.100
Bid Volume -
Ask Price 1.110
Ask Volume -
Volume 10,187
Value -
Remark
Delayed prices. Updated at 06 Dec 2025 01:02.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis